Market Cap 750.93M
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 4,427,800
Avg Vol 4,361,292
Day's Range N/A - N/A
Shares Out 297.99M
Stochastic %K 79%
Beta 0.50
Analysts Strong Sell
Price Target $11.71

Latest News on ABCL

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:26 PM EST - 7 weeks ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 7 weeks ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 4 months ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 6 months ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 8 months ago

AbCellera: A Waiting Game With High Uncertainty


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 9 months ago

AbCellera Reports Q2 2024 Business Results


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2024 Business Results


AbCellera Announces Resignation of Board Member

Feb 23, 2024, 4:30 PM EST - 1 year ago

AbCellera Announces Resignation of Board Member


AbCellera Reports Full Year 2023 Business Results

Feb 20, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2023 Business Results


AbCellera Reports Q3 2023 Business Results

Nov 2, 2023, 4:05 PM EDT - 1 year ago

AbCellera Reports Q3 2023 Business Results